Biztoc.com - September 18, 2024
JMP Securities initiated coverage on BeiGene Ltd (NASDAQ:BGNE), noting the Chinese biotech firm as a ‘unique investment opportunity.’ The company’s flagship drug, Brukinsa (zanubrutinib), is among the more recent BTK inhibitors to break into a global market p…
Read Full ArticleIvar recommends Swissquote bank for your international investments. By opening your account through the link below and trading 5 lots or more, you will receive $200 to use on Ivar AI and activate your subscription. Take advantage of this exclusive offer available today!
Offer available for you who have not yet opened your account at Swissquote.
Services available globally except for the following countries: Algeria, Belgium, Canada, China, North Korea, USA, France, Hong Kong, Iran, Iraq, Nigeria, Singapore, Syria, Turkey and Zimbabwe.
Av Norte Miguel Arraes de Alencar, 3003. CP974. Encruzilhada, Recife-PE, Brasil.
+55 81 99840-3982
support@ivar-ai.com
:format(jpg):quality(99):watermark(f.elconfidencial.com/file/bae/eea/fde/baeeeafde1b3229287b0c008f7602058.png,0,275,1)/f.elconfidencial.com/original/24f/c34/cf8/24fc34cf81b2d0b590978e0119f5e337.jpg)
